[Adoptive immunotherapy of malignancies].
The results of the studies show that mononuclear leukocytes isolated from human peripheral blood, malignant effusions, and surgically removed spleen can be generated into lymphokine-activated killers (LAK) characterized by high anti-tumor activity. LAKs may be used foradoptive immunotherapy of malignant effusions and the prevention of tumor recurrence in oncological patients after radical surgery.
Shubina
I Zh
IZh
Bliumenberg
A G
AG
Volkov
S M
SM
Demidov
L V
LV
Kiselevskiĭ
M V
MV
D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007694:Killer Cells, Natural / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology; D008854:Microscopy, Electron; D009369:Neoplasms / Q000628:therapy* / Q000648:ultrastructure*